{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T16:52:03Z","timestamp":1776617523694,"version":"3.51.2"},"reference-count":33,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2010,12,22]],"date-time":"2010-12-22T00:00:00Z","timestamp":1292976000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Transplantation"],"published-print":{"date-parts":[[2011,3]]},"abstract":"<jats:p>Nishio N, Takahashi Y, Ohashi H, Doisaki S, Muramatsu H, Hama A, Shimada A, Yagasaki H, Kojima S. Reduced\u2010intensity conditioning for alternative donor hematopoietic stem cell transplantation in patients with dyskeratosis congenita.\u2028Pediatr Transplantation 2011: 15:161\u2013166. \u00a9 2010 John Wiley &amp; Sons A\/S.<\/jats:p><jats:p><jats:bold>Abstract:\u2002<\/jats:bold> DC is an inherited bone marrow failure syndrome mainly characterized by nail dystrophy, abnormal skin pigmentation, and oral leukoplakia. Bone marrow failure is the most common cause of death in patients with DC. Because previous results of HSCT with a myeloablative regimen were disappointing, we used a reduced\u2010intensity conditioning regimen for two patients with classic DC, and one patient with cryptic DC who harbored the <jats:italic>TERT<\/jats:italic> mutation. Graft sources included two mismatched\u2010related bone marrow (BM) donors and one unrelated BM donor. Successful engraftment was achieved with few regimen\u2010related toxicities in all patients. They were alive 10, 66, and 72\u2003months after transplantation, respectively. Long\u2010term follow\u2010up is crucial to determine the late effects of our conditioning regimen.<\/jats:p>","DOI":"10.1111\/j.1399-3046.2010.01431.x","type":"journal-article","created":{"date-parts":[[2010,12,22]],"date-time":"2010-12-22T19:52:17Z","timestamp":1293047537000},"page":"161-166","source":"Crossref","is-referenced-by-count":44,"title":["Reduced\u2010intensity conditioning for alternative donor hematopoietic stem cell transplantation in patients with dyskeratosis congenita"],"prefix":"10.1111","volume":"15","author":[{"given":"Nobuhiro","family":"Nishio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruhiko","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayoko","family":"Doisaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Muramatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asahito","family":"Hama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Yagasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,12,22]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07598.x"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2007.11.003"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3046.2007.00721.x"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-12-192880"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703230"},{"key":"e_1_2_8_7_2","first-page":"656","article-title":"Mutations in telomerase catalytic protein in Japanese children with aplastic anemia","volume":"91","author":"Liang J","year":"2006","journal-title":"Haematologica"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.03087.x"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(80)90380-0"},{"key":"e_1_2_8_10_2","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka D","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2008.02.002"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3046.2008.01068.x"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3046.1999.00062.x"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1999.01437.x"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00949.x"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1700674"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.424984.x"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V80.12.3090.3090"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1991.tb04543.x"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00320601"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701567"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20696"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703844"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03835_2.x"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703931"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705171"},{"key":"e_1_2_8_27_2","article-title":"Disease\u2010specific hematopoietic cell transplantation: Nonmyeloablative conditioning regimen for dyskeratosis congenita","author":"Dietz AC","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2010.03.002"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705165"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2008.06.020"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2008.151"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704592"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcl.2010.01.002"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.03.129"}],"container-title":["Pediatric Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-3046.2010.01431.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-3046.2010.01431.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T21:57:53Z","timestamp":1698789473000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-3046.2010.01431.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,22]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["10.1111\/j.1399-3046.2010.01431.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-3046.2010.01431.x","archive":["Portico"],"relation":{},"ISSN":["1397-3142","1399-3046"],"issn-type":[{"value":"1397-3142","type":"print"},{"value":"1399-3046","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,22]]}}}